Info

We offer a range of services that use our proprietary antigen identification and immunoproteomics technologies to identify panels of naturally processed MHC Class I and Class II-associated peptides for customer-specified indications. The products of our analysis include MHC-processed antigens for development of immunotherapeutic vaccines, antibody targets and diagnostics. Our technology platform can be applied to the identification of antigens for cancer, infectious diseases, autoimmune disorders and bacterial and fungal diseases where MHC processing and presentation of antigens is critical to eliciting a protective immune response. We have expertise in autoantigen identification and screen serum autoantibodies to identify novel diagnostic and antibody therapeutic targets. Our services also include: Analysis of MHC processing of proteins in genetic constructs Analysis of antigen specificity post cell-based immunotherapies ..................................................................................................................................................................... Clinical and Preclinical Programs | Science & Technology | CareersBusiness Development | Services | Management and Boards | News and Media | Contact Us | Home